No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Is Organon & Co. (OGN) the Best Medical Stock to Buy Under $20?
Organon Snaps Six Days of Winning Streak
Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference
Goldman Sachs Maintains Organon & Co(OGN.US) With Hold Rating, Maintains Target Price $20
Organon Gets Expanded FDA Approval for VTAMA
Organon Says Vtama Cream Approved by FDA for Atopic Dermatitis